InvestorsHub Logo
Followers 33
Posts 3718
Boards Moderated 0
Alias Born 10/31/2008

Re: None

Friday, 10/31/2014 9:13:43 AM

Friday, October 31, 2014 9:13:43 AM

Post# of 146196
Ebola: The making of a $1 billion drug

And NVNC is in the game!

If they can pull this off, the advantages are legion:

- In humans almost a year early
- Validation of the rapid development platform
- Revenues from sales
- Move from pre-clinical status to clinical biopharma status
- Serious money from grants to expand production
- and the list goes on

http://money.cnn.com/2014/10/28/news/companies/ebola-drug-billion/index.html

"When someone shows you who they are, believe them." - Maya Angelou

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News